Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Open access
3,339
Views
6
CrossRef citations to date
0
Altmetric
Coronaviruses
Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein
Sheng Jianga Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College (SHMC), Fudan University, Shanghai, People’s Republic of China;b National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Shuting Wua Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College (SHMC), Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Gan Zhaoc Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou, Jiangsu Province, People’s Republic of ChinaView further author information
, Yue Hec Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou, Jiangsu Province, People’s Republic of ChinaView further author information
, Xinrong Guod Colby College, Waterville, ME, USAView further author information
, Zhiyu Zhangc Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou, Jiangsu Province, People’s Republic of ChinaView further author information
, Jiawang Houc Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou, Jiangsu Province, People’s Republic of ChinaView further author information
, Yuan Dingc Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou, Jiangsu Province, People’s Republic of ChinaView further author information
, Alex Chengc Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou, Jiangsu Province, People’s Republic of ChinaView further author information
& Bin Wanga Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College (SHMC), Fudan University, Shanghai, People’s Republic of China;b National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China;c Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou, Jiangsu Province, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-9945-1818View further author information
Pages 730-740
|
Received 01 Dec 2021, Accepted 14 Feb 2022, Published online: 01 Mar 2022
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.